Characterization of Patients with KRAS-Mutated Advanced Non-Small Cell Lung Cancer

被引：1
|
作者：
Sousa, Catarina C. [1 ]
Pinto, Josue [1 ]
Martins, Natalia [1 ,2 ,3 ]
Teixeira, Sofia [4 ]
Magalhaes, Adriana [1 ]
Fernandes, Gabriela [1 ,2 ,3 ]
Hespanhol, Venceslau [1 ,2 ,3 ]
Queiroga, Henrique [1 ,2 ,3 ]
Bastos, Helder Novais [1 ,2 ,3 ]
机构：
[1] Univ Hosp Ctr Sao Joao, Dept Pulmonol, Porto, Portugal
[2] Univ Porto, Fac Med, Porto, Portugal
[3] Univ Porto, Inst Res & Innovat Hlth, Porto, Portugal
[4] Univ Minho, Life & Hlth Sci Res Inst ICVS, Braga, Portugal
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷
关键词：
D O I：
10.1183/13993003.congress-2019.PA4684
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA4684
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Stratification of patients with KRAS-mutated advanced non-small cell lung cancer: improving prognostics
    Zhang, Yuda
    Zeng, Fanxu
    Peng, Shixuan
    Chen, Yangqian
    Jiang, Wenjuan
    Wang, Zhan
    Deng, Li
    Huang, Zhe
    Qin, Haoyue
    Yan, Huan
    Zhang, Xing
    Zhang, Lin
    Yang, Nong
    Gong, Qian
    Zeng, Liang
    Zhang, Yongchang
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2023, 17 (09) : 743 - 751
  • [2] Realities of KRAS-mutated non-small cell lung cancer
    Min, Young Joo
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (03): : 442 - 442
  • [3] Characterization of Patients with KRAS-Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Community Practice Setting
    Zhang, L.
    Carter, G. Cuyun
    Beyrer, J.
    Li, L.
    Sheffield, K.
    Muehlenbein, C.
    Boye, M.
    Molife, C.
    Frantz, K.
    John, W.
    Gadgeel, S. M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1571 - S1571
  • [4] Management of KRAS-Mutated Non-Small Cell Lung Cancer
    Malhotra, Jyoti
    Nguyen, Danny
    Tan, Tingting
    Semeniuk, George B.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (02) : 67 - 75
  • [5] Neighborhood disadvantage is associated with KRAS-mutated non-small cell lung cancer risk
    Wing, Sam E.
    Jankowska, Marta M.
    Zou, Xiaoke
    Sosa, Ernesto
    Yang, Jiue-An
    Benmarhnia, Tarik
    Neuhausen, Susan L.
    Nelson, Rebecca
    Salgia, Ravi
    Gray, Stacy W.
    Erhunmwunsee, Loretta
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (08) : 5231 - 5240
  • [6] Neighborhood disadvantage is associated with KRAS-mutated non-small cell lung cancer risk
    Sam E. Wing
    Marta M. Jankowska
    Xiaoke Zou
    Ernesto Sosa
    Jiue-An Yang
    Tarik Benmarhnia
    Susan L. Neuhausen
    Rebecca Nelson
    Ravi Salgia
    Stacy W. Gray
    Loretta Erhunmwunsee
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 5231 - 5240
  • [7] Definitive Chemoradiation and Durvalumab Consolidation for Locally Advanced, Unresectable KRAS-mutated Non-Small Cell Lung Cancer
    Guo, Matthew Z.
    Murray, Joseph C.
    Ghanem, Paola
    Voong, K. Ranh
    Hales, Russell K.
    Ettinger, David
    Lam, Vincent K.
    Hann, Christine L.
    Forde, Patrick M.
    Brahmer, Julie R.
    Levy, Benjamin P.
    Feliciano, Josephine L.
    Marrone, Kristen A.
    CLINICAL LUNG CANCER, 2022, 23 (07) : 620 - 629
  • [8] A RAS Renaissance: Emerging Targeted Therapies for KRAS-Mutated Non-Small Cell Lung Cancer
    Vasan, Neil
    Boyer, Julie L.
    Herbst, Roy S.
    CLINICAL CANCER RESEARCH, 2014, 20 (15) : 3921 - 3930
  • [9] Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer
    O'Sullivan, Eabha
    Keogh, Anna
    Henderson, Brian
    Finn, Stephen P.
    Gray, Steven G.
    Gately, Kathy
    CANCERS, 2023, 15 (06)
  • [10] Role of Immune Checkpoint Inhibitors (ICPi) in KRAS-Mutated Non-Small Cell Lung Cancer (NSCLC)
    Peravali, M.
    Gomes-Lima, C.
    Tefera, E.
    Baker, M.
    Sherchan, M.
    Farid, S.
    Burman, K.
    Constantinescu, F.
    Veytsman, I.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S300 - S301
12345